Prospective validation of a perinatal bacterial vaginosis screening risk score

Lisa M. Pastore, Tonya S. King, Ida J. Dawson, Alisa Hollifield, John M. Thorp

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: Prospectively validate an antenatal bacterial vaginosis (BV) risk score at two public health department obstetrics clinics. Study Design: Women (n = 409) entering prenatal care received a BV risk score (range 0 to 16) at their first visit and at 24 to 28 weeks' gestation. BV was measured with Gram-stained vaginal smears. Normal discharge was used as a surrogate for being asymptomatic. Results: Approximately half of the women scored ≥3 at each assessment. In total 29% had true BV at the first assessment (13% at the second assessment). The BV risk score, (≥3) had 9% sensitivity and 63% specificity, and the BV risk score (≥5) had 88% sensitivity and 76% specificity. Among true cases, 42% were asymptomatic, of which 77% had risk scores ≥3. All symptomatic BV cases had risk scores ≥3. Conclusion: In practice, the risk score identified both asymptomatic and symptomatic cases. Asymptomatic women are of particular interest because they are not screened for BV under current practice guidelines.

Original languageEnglish (US)
Pages (from-to)735-742
Number of pages8
JournalJournal of Perinatology
Volume24
Issue number12
DOIs
StatePublished - Dec 1 2004

Fingerprint

Bacterial Vaginosis
Sensitivity and Specificity
Hospital Obstetrics and Gynecology Department
Vaginal Smears
Prenatal Care
Practice Guidelines
Public Health
Pregnancy

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Pastore, Lisa M. ; King, Tonya S. ; Dawson, Ida J. ; Hollifield, Alisa ; Thorp, John M. / Prospective validation of a perinatal bacterial vaginosis screening risk score. In: Journal of Perinatology. 2004 ; Vol. 24, No. 12. pp. 735-742.
@article{8b2616e47b01467b96e72cdcd178330b,
title = "Prospective validation of a perinatal bacterial vaginosis screening risk score",
abstract = "Objective: Prospectively validate an antenatal bacterial vaginosis (BV) risk score at two public health department obstetrics clinics. Study Design: Women (n = 409) entering prenatal care received a BV risk score (range 0 to 16) at their first visit and at 24 to 28 weeks' gestation. BV was measured with Gram-stained vaginal smears. Normal discharge was used as a surrogate for being asymptomatic. Results: Approximately half of the women scored ≥3 at each assessment. In total 29{\%} had true BV at the first assessment (13{\%} at the second assessment). The BV risk score, (≥3) had 9{\%} sensitivity and 63{\%} specificity, and the BV risk score (≥5) had 88{\%} sensitivity and 76{\%} specificity. Among true cases, 42{\%} were asymptomatic, of which 77{\%} had risk scores ≥3. All symptomatic BV cases had risk scores ≥3. Conclusion: In practice, the risk score identified both asymptomatic and symptomatic cases. Asymptomatic women are of particular interest because they are not screened for BV under current practice guidelines.",
author = "Pastore, {Lisa M.} and King, {Tonya S.} and Dawson, {Ida J.} and Alisa Hollifield and Thorp, {John M.}",
year = "2004",
month = "12",
day = "1",
doi = "10.1038/sj.jp.7211179",
language = "English (US)",
volume = "24",
pages = "735--742",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "12",

}

Prospective validation of a perinatal bacterial vaginosis screening risk score. / Pastore, Lisa M.; King, Tonya S.; Dawson, Ida J.; Hollifield, Alisa; Thorp, John M.

In: Journal of Perinatology, Vol. 24, No. 12, 01.12.2004, p. 735-742.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prospective validation of a perinatal bacterial vaginosis screening risk score

AU - Pastore, Lisa M.

AU - King, Tonya S.

AU - Dawson, Ida J.

AU - Hollifield, Alisa

AU - Thorp, John M.

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Objective: Prospectively validate an antenatal bacterial vaginosis (BV) risk score at two public health department obstetrics clinics. Study Design: Women (n = 409) entering prenatal care received a BV risk score (range 0 to 16) at their first visit and at 24 to 28 weeks' gestation. BV was measured with Gram-stained vaginal smears. Normal discharge was used as a surrogate for being asymptomatic. Results: Approximately half of the women scored ≥3 at each assessment. In total 29% had true BV at the first assessment (13% at the second assessment). The BV risk score, (≥3) had 9% sensitivity and 63% specificity, and the BV risk score (≥5) had 88% sensitivity and 76% specificity. Among true cases, 42% were asymptomatic, of which 77% had risk scores ≥3. All symptomatic BV cases had risk scores ≥3. Conclusion: In practice, the risk score identified both asymptomatic and symptomatic cases. Asymptomatic women are of particular interest because they are not screened for BV under current practice guidelines.

AB - Objective: Prospectively validate an antenatal bacterial vaginosis (BV) risk score at two public health department obstetrics clinics. Study Design: Women (n = 409) entering prenatal care received a BV risk score (range 0 to 16) at their first visit and at 24 to 28 weeks' gestation. BV was measured with Gram-stained vaginal smears. Normal discharge was used as a surrogate for being asymptomatic. Results: Approximately half of the women scored ≥3 at each assessment. In total 29% had true BV at the first assessment (13% at the second assessment). The BV risk score, (≥3) had 9% sensitivity and 63% specificity, and the BV risk score (≥5) had 88% sensitivity and 76% specificity. Among true cases, 42% were asymptomatic, of which 77% had risk scores ≥3. All symptomatic BV cases had risk scores ≥3. Conclusion: In practice, the risk score identified both asymptomatic and symptomatic cases. Asymptomatic women are of particular interest because they are not screened for BV under current practice guidelines.

UR - http://www.scopus.com/inward/record.url?scp=10244266273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10244266273&partnerID=8YFLogxK

U2 - 10.1038/sj.jp.7211179

DO - 10.1038/sj.jp.7211179

M3 - Article

C2 - 15306827

AN - SCOPUS:10244266273

VL - 24

SP - 735

EP - 742

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 12

ER -